( en | de | ru )

 

Disambiguation of "Godwin, Andrew K."

Author of the publication

copydeleteadd this publication to your clipboard
Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples

, , , , , , , , and . Scientific Reports, (July 2015)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Godwin Shiri

Godwin Lämmermann

Godwin Dziambor

Godwin Jeschal

John Godwin

 

Other publications of authors with the same name

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers, , , , , , , , , and 171 other author(s). Breast cancer research : BCR, 14 (1): R33 (2012)A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population, , , , , , , , , and 168 other author(s). Nature genetics, 42 (10): 885–892 (2010)Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 58 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19 (11): 2859–2868 (2010)Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 127 other author(s). Human molecular genetics, 18 (22): 4442–4456 (2009)AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study, , , , , , , , , and 61 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 16 (7): 1416–1421 (2007)Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients, , , , , , , , , and 725 other author(s). Cancer Cell, 34 (2): 211--224.e6 (August 2018)Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines, , , , , , , , , and 730 other author(s). Cell Systems, 6 (3): 271--281.e7 (March 2018)Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 180 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (4): 645–657 (2012)Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , and 427 other author(s). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), , , , , , , , , and 123 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)